Requirement for BAFF and APRIL during B cell development in GALT.
The effects of B cell-activating factor belonging to the TNF family (BAFF) on B cell maturation and survival in the mouse are relatively well understood. In contrast, little is known about the role of BAFF in B cell development in other mammals, such as rabbits, that use GALT to develop and maintain the B cell compartment. We examined the expression and requirement of BAFF and a proliferation-inducing ligand (APRIL) during peripheral B cell development in young rabbits. By neutralizing BAFF and APRIL in neonates with a soluble decoy receptor, transmembrane activator calcium modulator and cyclophilin ligand interactor-Fc, we found a marked reduction in the number of peripheral B cells, but found no change in the bone marrow (BM) compartment. In the appendix, the size and number of proliferating B cell follicles were greatly reduced, demonstrating that although BAFF/APRIL is dispensable for B cell development in BM, it is required for B cell development in GALT. We found that all rabbit B cells expressed BAFF receptor 3, but did not bind rBAFF, suggesting that the BAFF-binding receptors (BBRs) are bound by endogenous soluble BAFF. Further, we found that B cells themselves express BAFF, suggesting that the soluble BAFF bound to BBRs may be endogenously produced and stimulate B cells in an autocrine fashion. Additionally, we propose that this chronic occupancy of BBRs on B cells may provide a tonic and/or survival signal for the maintenance of peripheral B cells in adults after B lymphopoiesis is arrested in BM.
Yeramilli
Venkata A
VA
Department of Microbiology and Immunology, Strich School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA.
Knight
Katherine L
KL
D000375:Aging / Q000276:immunology; D000818:Animals; D000831:Animals, Newborn; D053264:B-Cell Activating Factor / Q000096:biosynthesis / Q000378:metabolism / Q000502:physiology*; D053265:B-Cell Activation Factor Receptor / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism; D016175:B-Lymphocyte Subsets / Q000166:cytology / Q000276:immunology* / Q000378:metabolism; D001854:Bone Marrow Cells / Q000166:cytology / Q000276:immunology / Q000378:metabolism; D016466:CHO Cells; D002454:Cell Differentiation / Q000276:immunology*; D002460:Cell Line; D049109:Cell Proliferation; D006224:Cricetinae; D003412:Cricetulus; D041981:Gastrointestinal Tract / Q000166:cytology / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D008024:Ligands; D008221:Lymphoid Tissue / Q000166:cytology / Q000276:immunology* / Q000378:metabolism; D038041:Lymphopoiesis / Q000276:immunology; D011817:Rabbits; D053300:Tumor Necrosis Factor Ligand Superfamily Member 13 / Q000378:metabolism / Q000502:physiology*
D053264:B-Cell Activating Factor; D053265:B-Cell Activation Factor Receptor; D008024:Ligands; D053300:Tumor Necrosis Factor Ligand Superfamily Member 13
J Immunol. 2009 Sep 15;183(6):3561-7
19726767
J Immunol. 2004 Jan 15;172(2):1118-24
14707086
Ann Rheum Dis. 2003 Feb;62(2):168-71
12525388
J Immunol. 2004 Mar 1;172(5):3268-79
14978135
Mol Cell Biol. 2004 Feb;24(3):997-1006
14729948
J Immunol. 2001 Jan 1;166(1):6-10
11123269
Vet Immunol Immunopathol. 2009 Jul 15;130(1-2):125-30
19269694
Dev Comp Immunol. 2008;32(8):980-91
18329710
Proc Natl Acad Sci U S A. 1988 May;85(9):3130-4
2834733
J Exp Med. 2000 Jul 3;192(1):129-35
10880534
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13945-50
19666484
Int Immunol. 2007 Feb;19(2):203-15
17220480
Blood. 2008 Mar 1;111(5):2744-54
18172003
Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3903-8
14988498
J Biol Chem. 2000 Nov 10;275(45):35478-85
10956646
J Exp Med. 1998 Sep 21;188(6):1185-90
9743536
Adv Exp Med Biol. 1994;355:249-53
7709830
J Exp Med. 1996 May 1;183(5):2119-21
8642322
Immunity. 2001 Aug;15(2):289-302
11520463
J Immunol. 2008 Jul 15;181(2):1012-8
18606652
Mol Immunol. 2007 Feb;44(6):1471-6
16828163
Arthritis Rheum. 2005 Dec;52(12):3943-54
16320342
Immunol Rev. 2000 Jun;175:214-28
10933605
J Immunol. 2007 Nov 1;179(9):5947-57
17947668
Science. 2001 Sep 14;293(5537):2108-11
11509692
J Exp Med. 2000 Nov 20;192(10):1453-66
11085747
Nature. 2000 Apr 27;404(6781):995-9
10801128
J Immunol. 1996 Dec 15;157(12):5478-86
8955197
Nat Genet. 2005 Aug;37(8):820-8
16007087
J Exp Med. 1999 Jun 7;189(11):1747-56
10359578
Cytokine. 2007 Sep;39(3):192-200
17822916
Cell. 1991 Mar 8;64(5):995-1005
1900459
Blood. 2009 Feb 26;113(9):1967-76
18981294
Nat Immunol. 2000 Sep;1(3):252-6
10973284
Immunity. 1994 Nov;1(8):647-59
7600292
Dev Comp Immunol. 2009 May;33(5):697-708
19124039
J Exp Med. 2004 Jan 5;199(1):91-8
14707116
J Clin Invest. 2006 Dec;116(12):3266-76
17111048
J Immunol. 1998 Mar 15;160(6):2725-9
9510172
Dev Comp Immunol. 2007;31(12):1211-9
17499850
Int Immunol. 2004 Jan;16(1):139-48
14688069
Adv Immunol. 1994;56:179-218
8073947
Science. 2001 Sep 14;293(5537):2111-4
11509691
J Clin Invest. 2003 Jul;112(2):286-97
12865416
Arthritis Rheum. 2001 Jun;44(6):1313-9
11407690
Int Rev Immunol. 1997;15(3-4):165-83
9222818
Immunology. 2000 May;100(1):119-30
10809967
J Exp Med. 1999 Dec 6;190(11):1697-710
10587360
Dev Comp Immunol. 2008;32(9):1076-87
18395254
Methods. 2001 Dec;25(4):402-8
11846609
J Immunol. 2002 Jun 1;168(11):5605-11
12023357
J Immunol. 2003 Dec 15;171(12):6372-80
14662835
J Immunol. 2007 May 1;178(9):5612-22
17442944
J Exp Med. 2008 Jan 21;205(1):155-68
18180309
Res Immunol. 1993 Jul-Sep;144(6-7):486-91; discussion 491-4
8303070
Nat Immunol. 2001 Jul;2(7):638-43
11429549
Blood. 2001 Jan 1;97(1):198-204
11133761
Int Arch Allergy Appl Immunol. 1968;33(1):65-88
4171257
J Immunol. 2008 Jul 15;181(2):976-90
18606649
Nat Rev Immunol. 2009 Jul;9(7):491-502
19521398
Leukemia. 1994 Dec;8(12):2144-55
7808003